In a “quadruple-mutant” model of colorectal cancer, TGF-β signaling acts as a primary defense mechanism that shields the tumor by both physically excluding cancer-killing T-cells and deactivating any that manage to get close [182]. Here, TGFB1 is linked to neoplasm.